Trial · NCT00810732
Results by group42
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 42
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Mean 24-Hour Urine Total Protein Level at Week 6 | Sitaxsentan | Baseline | 2.07 | Standard Deviation 1.77 | Grams per 24 hours |
| Change From Baseline in Mean 24-Hour Urine Total Protein Level at Week 6 | Placebo | Baseline | 2.07 | Standard Deviation 1.96 | Grams per 24 hours |
| Change From Baseline in Mean 24-Hour Urine Total Protein Level at Week 6 | Nifedipine | Baseline | 1.95 | Standard Deviation 1.58 | Grams per 24 hours |
| Change From Baseline in Mean 24-Hour Urine Total Protein Level at Week 6 | Sitaxsentan | Change at week 6 | -0.62 | Standard Deviation 0.56 | Grams per 24 hours |
| Change From Baseline in Mean 24-Hour Urine Total Protein Level at Week 6 | Placebo | Change at week 6 | -0.06 | Standard Deviation 0.89 | Grams per 24 hours |
| Change From Baseline in Mean 24-Hour Urine Total Protein Level at Week 6 | Nifedipine | Change at week 6 | 0.01 | Standard Deviation 0.77 | Grams per 24 hours |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Sitaxsentan | Mean Systemic Arterial BP: Baseline | 92.94 | Standard Deviation 7.39 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Placebo | Mean Systemic Arterial BP: Baseline | 92.98 | Standard Deviation 9.33 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Nifedipine | Mean Systemic Arterial BP: Baseline | 93.78 | Standard Deviation 8.35 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Sitaxsentan | Mean Systemic Arterial BP: Change at Week 3 | -4.59 | Standard Deviation 5.02 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Placebo | Mean Systemic Arterial BP: Change at Week 3 | -1.20 | Standard Deviation 4.70 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Nifedipine | Mean Systemic Arterial BP: Change at Week 3 | -2.95 | Standard Deviation 5.90 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Sitaxsentan | Mean Systemic Arterial BP: Change at Week 6 | -3.74 | Standard Deviation 5.62 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Placebo | Mean Systemic Arterial BP: Change at Week 6 | -0.35 | Standard Deviation 5.38 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Nifedipine | Mean Systemic Arterial BP: Change at Week 6 | -3.54 | Standard Deviation 5.49 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Sitaxsentan | Mean Systemic Arterial SBP :Baseline | 124.03 | Standard Deviation 11.44 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Placebo | Mean Systemic Arterial SBP :Baseline | 125.17 | Standard Deviation 13.95 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Nifedipine | Mean Systemic Arterial SBP :Baseline | 125.12 | Standard Deviation 12.33 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Sitaxsentan | Mean Systemic Arterial SBP: Change at Week 3 | -4.88 | Standard Deviation 7.34 | Millimeter of Mercury (mmHg) |
| Change From Baseline in Mean Systemic Arterial Blood Pressure (BP), Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP) at Week 3 and 6 | Placebo | Mean Systemic Arterial SBP: Change at Week 3 | -2.81 | Standard Deviation 7.21 | Millimeter of Mercury (mmHg) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00810732/results